Article
RVD With Weekly Bortezomib Has a Favorable Toxicity and Effectiveness Profile in a Large Cohort of US Veterans With Multiple Myeloma
- Author:
- Sarvari Yellapragada, MD
Publish date: September 10, 2024
Article
The First Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors T-cell Therapy for Refractory Multiple Myeloma and the Role of Intravenous Immunoglobulin in the Prevention of Therapy-associated Infections
- Author:
- Sarvari Yellapragada, MD
Publish date: September 9, 2024
Article
The First Female Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors (CAR) T-cell Therapy for Refractory Multiple Myeloma and the Role of CAR T-cell Therapy in Penta-refractory Disease
- Author:
- Sarvari Yellapragada, MD
Publish date: September 9, 2024